Therefore, we chose two FAB subtypes of the AML cell lines mentioned above, HL60 (M2) and MV4–11 (M5), for exogenous GPR132 expression using a Tet-based inducible expression system to determine its function in leukemogenic activities. This evidence concerns the gene FANCB and acute myeloid leukemia.